drugset
Drugs / grape seed polyphenolic extract
last change Jun 2022 re-read 2 minutes ago

grape seed polyphenolic extract

also known as GSE · Meganatural-Az Grapeseed Extract
Developed for
Alzheimer disease · cognitive impairment with or without cerebellar ataxia
Investigated by
Icahn School of Medicine at Mount Sinai · Johns Hopkins University

Trials 1 · a red edge is where a trial was stopped

today NCT02502253 · Ph 1
201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02502253 Jun 2015 → Jun 2022 Alzheimer disease, cognitive impairment with or without cerebellar ataxia Johns Hopkins University Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02033941 Comparator Jul 2018 → Oct 2019 Alzheimer disease Hillel Grossman Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as grape seed polyphenolic extract ClinicalTrials.gov intervention name — accepted as the source's own label NCT02502253 ↗
Known as GSE “Bioactive Dietary Polyphenol Preparation (BDPP) is a combination of two nutraceutical preparations (grape seed polyphenolic extract \[GSE\], and resveratrol) that contain...” NCT02502253 ↗
Known as Meganatural-Az Grapeseed Extract ClinicalTrials.gov intervention name — accepted as the source's own label NCT02033941 ↗